Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Simvastatin 20 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Simvastatin 20 mg Tablet is a lipid-lowering agent belonging to the class of HMG-CoA reductase inhibitors, commonly known as statins. It helps reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C). Simvastatin acts by inhibiting the HMG-CoA reductase enzyme in the liver, which is crucial for cholesterol synthesis, thereby reducing circulating cholesterol levels and slowing the progression of atherosclerosis. The 20 mg strength is often used as a standard therapeutic dose for patients with moderate to severe hypercholesterolemia or those requiring additional cardiovascular risk reduction. When combined with lifestyle changes such as diet and exercise, Simvastatin 20 mg significantly lowers the risk of heart attack, stroke, and other cardiovascular events in high-risk patients.
Common side effects include headache, abdominal pain, constipation, nausea, and mild muscle aches. Rare but serious adverse effects include myopathy, rhabdomyolysis, and elevated liver enzymes, especially at higher doses or when combined with interacting drugs. The risk of muscle toxicity increases with concomitant use of potent CYP3A4 inhibitors or fibrates. Patients should report unexplained muscle pain, tenderness, or weakness immediately. Routine monitoring of liver function tests and lipid profiles is recommended during long-term use.
Simvastatin 20 mg Tablet is indicated for the treatment of primary hypercholesterolemia, mixed dyslipidemia, and hypertriglyceridemia. It is also used in the primary and secondary prevention of cardiovascular events in patients with coronary artery disease, diabetes, or multiple cardiovascular risk factors to reduce the likelihood of myocardial infarction, stroke, and the need for revascularization procedures.
Simvastatin 20 mg should be taken only under medical supervision and in conjunction with lifestyle modifications for optimal effect. It is contraindicated in pregnancy and breastfeeding as statins may harm fetal development. The medication is also contraindicated in patients with active liver disease or persistent unexplained elevations in liver transaminases. Alcohol intake should be minimized to reduce liver stress. Patients should avoid grapefruit juice while on Simvastatin, as it can increase drug levels and risk of adverse effects. Regular follow-up with lipid panels and liver function tests is essential to ensure safety and effectiveness.
Store Simvastatin 20 mg Tablet in a cool, dry place at a temperature below 30°C. Keep it protected from moisture and direct sunlight. Store in its original packaging and keep out of reach of children and pets. Do not use after the expiry date printed on the label.
Composition : Simvastatin 10 mg tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 40 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Simvastatin 20 mg Tablet is a statin-class lipid-lowering medicine used for the treatment of high cholesterol, dyslipidemia, and prevention of cardiovascular diseases such as heart attack and stroke. It works by reducing cholesterol synthesis in the liver, helping improve overall lipid profiles and cardiovascular health. As a widely prescribed cardiovascular and chronic care product, it offers strong potential in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for cholesterol-management therapies. Simvastatin 20 mg is commonly prescribed for long-term cardiovascular risk management, ensuring regular repeat prescriptions, stable sales volumes, and continuous demand from retail pharmacies, hospitals, and healthcare providers.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiovascular and lipid-management segment, including Simvastatin 20 mg Tablet. We provide monopoly rights, quality-assured manufacturing, promotional support, and reliable product availability to help franchise partners establish a strong presence in the cardiac care market.
Wholesalers and stockists benefit from strong prescription-driven demand, long-term patient dependency, and widespread acceptance among cardiologists and physicians. Since cholesterol-lowering therapy is often required for extended periods, this product offers steady product movement, repeat business opportunities, and sustainable profitability in pharmaceutical distribution.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and lipid-lowering products can contact Cafoli Lifecare to discuss pricing, product availability, monopoly franchise rights, and PCD pharma franchise opportunities. We provide complete support through marketing materials, dependable supply chains, and territory-based franchise assistance to help partners grow their pharmaceutical business successfully.